HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 365 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,138,488 | +17.6% | 40,843 | -8.6% | 0.00% | 0.0% |
| Q1 2024 | $1,818,242 | +7.2% | 44,696 | -2.6% | 0.00% | 0.0% |
| Q4 2023 | $1,696,533 | -24.4% | 45,901 | -21.8% | 0.00% | -33.3% |
| Q3 2023 | $2,242,646 | -14.6% | 58,708 | -19.4% | 0.01% | -14.3% |
| Q2 2023 | $2,626,715 | +87457.2% | 72,824 | -7.3% | 0.01% | -22.2% |
| Q1 2023 | $3,000 | -35.7% | 78,561 | -4.1% | 0.01% | -40.0% |
| Q4 2022 | $4,663 | -99.9% | 81,955 | -1.8% | 0.02% | +15.4% |
| Q3 2022 | $3,300,000 | +600.6% | 83,458 | +680.3% | 0.01% | +550.0% |
| Q2 2022 | $471,000 | – | 10,696 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $206,177,000 | 28.12% |
| BB BIOTECH AG | 8,322,860 | $121,763,000 | 3.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 398,633 | $4,579,000 | 2.84% |
| DOHENY ASSET MANAGEMENT /CA | 227,193 | $3,324,000 | 2.43% |
| SNYDER CAPITAL MANAGEMENT L P | 2,833,759 | $41,458,000 | 2.24% |
| First Light Asset Management, LLC | 938,399 | $13,729,000 | 2.19% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,027,164 | $132,067,000 | 1.77% |
| Taylor Wealth Management Partners | 204,277 | $2,989,000 | 1.72% |
| Sterling Global Strategies LLC | 22,000 | $321,860,000 | 1.63% |
| Granite Investment Partners, LLC | 988,939 | $14,468,000 | 1.06% |